scholarly journals Characterization of DNA Substrate Binding to the Phosphatase Domain of the DNA Repair Enzyme Polynucleotide Kinase/Phosphatase

Biochemistry ◽  
2017 ◽  
Vol 56 (12) ◽  
pp. 1737-1745 ◽  
Author(s):  
Zahra Havali-Shahriari ◽  
Michael Weinfeld ◽  
J. N. Mark Glover
2009 ◽  
Vol 37 (18) ◽  
pp. 6161-6173 ◽  
Author(s):  
N. K. Bernstein ◽  
M. Hammel ◽  
R. S. Mani ◽  
M. Weinfeld ◽  
M. Pelikan ◽  
...  

DNA Repair ◽  
2012 ◽  
Vol 11 (10) ◽  
pp. 811-822 ◽  
Author(s):  
Xiaoming Yang ◽  
Jinjiang Fan ◽  
Alexander A. Ishchenko ◽  
Devang Patel ◽  
Murat K. Saparbaev ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (12) ◽  
pp. e0237682
Author(s):  
Luis Bermúdez-Guzmán ◽  
Gabriel Jimenez-Huezo ◽  
Andrés Arguedas ◽  
Alejandro Leal

The molecular function of a protein relies on its structure. Understanding how variants alter structure and function in multidomain proteins is key to elucidate the generation of a pathological phenotype. However, one may fall into the logical bias of assessing protein damage only based on the variants that are visible (survivorship bias), which can lead to partial conclusions. This is the case of PNKP, an important nuclear and mitochondrial DNA repair enzyme with both kinase and phosphatase function. Most variants in PNKP are confined to the kinase domain, leading to a pathological spectrum of three apparently distinct clinical entities. Since proteins and domains may have a different tolerability to variation, we evaluated whether variants in PNKP are under survivorship bias. Here, we provide the evidence that supports a higher tolerance in the kinase domain even when all variants reported are deleterious. Instead, the phosphatase domain is less tolerant due to its lower variant rates, a higher degree of sequence conservation, lower dN/dS ratios, and the presence of more disease-propensity hotspots. Together, our results support previous experimental evidence that demonstrated that the phosphatase domain is functionally more necessary and relevant for DNA repair, especially in the context of the development of the central nervous system. Finally, we propose the term "Wald’s domain" for future studies analyzing the possible survivorship bias in multidomain proteins.


2007 ◽  
Vol 101 (7) ◽  
pp. 1043-1048 ◽  
Author(s):  
Boris Bleijlevens ◽  
Tara Shivarattan ◽  
Barbara Sedgwick ◽  
Stephen E.J. Rigby ◽  
Steve J. Matthews

Biochemistry ◽  
2004 ◽  
Vol 43 (28) ◽  
pp. 8911-8922 ◽  
Author(s):  
Bidisha Bose-Basu ◽  
Eugene F. DeRose ◽  
Thomas W. Kirby ◽  
Geoffrey A. Mueller ◽  
William A. Beard ◽  
...  

2014 ◽  
Vol 70 (11) ◽  
pp. 2937-2949 ◽  
Author(s):  
Andrea F. Moon ◽  
Philippe Gaudu ◽  
Lars C. Pedersen

The group B pathogenStreptococcus agalactiaecommonly populates the human gut and urogenital tract, and is a major cause of infection-based mortality in neonatal infants and in elderly or immunocompromised adults. Nuclease A (GBS_NucA), a secreted DNA/RNA nuclease, serves as a virulence factor forS. agalactiae, facilitating bacterial evasion of the human innate immune response. GBS_NucA efficiently degrades the DNA matrix component of neutrophil extracellular traps (NETs), which attempt to kill and clear invading bacteria during the early stages of infection. In order to better understand the mechanisms of DNA substrate binding and catalysis of GBS_NucA, the high-resolution structure of a catalytically inactive mutant (H148G) was solved by X-ray crystallography. Several mutants on the surface of GBS_NucA which might influence DNA substrate binding and catalysis were generated and evaluated using an imidazole chemical rescue technique. While several of these mutants severely inhibited nuclease activity, two mutants (K146R and Q183A) exhibited significantly increased activity. These structural and biochemical studies have greatly increased our understanding of the mechanism of action of GBS_NucA in bacterial virulence and may serve as a foundation for the structure-based drug design of antibacterial compounds targeted toS. agalactiae.


2006 ◽  
Vol 110 (39) ◽  
pp. 19652-19663 ◽  
Author(s):  
Lesley R. Rutledge ◽  
Lachlan S. Campbell-Verduyn ◽  
Ken C. Hunter ◽  
Stacey D. Wetmore

Sign in / Sign up

Export Citation Format

Share Document